Management of Hepatitis C Infection with Direct Action Antiviral Drugs (DAA)**

• المؤلفون الرئيسيون: Roberto Focaccia (مؤلف), Rodolfo Ferreira de Mello (مؤلف), Patrícia Silva Montes (مؤلف), Flávio Martin Conti (مؤلف)
• التنسيق: كتاب
• منشور في: Archives of Hepatitis Research - Peertechz Publications, 2015-12-30.
• الموضوعات: Review Article
• الوصول للمادة أونلاين: Connect to this object online.

<p>Several new direct action antiviral drugs (DAA) against the HCV virus (HCV) are approved and marketed. The combination of DAA with pegylated interferon and ribavirin (PR) is only recommended to patients with tolerance to interferon (IFN). IFN-free treatments are now considered elective drug...